ConductScience.org, home

Paper277207

The rationale for the development of improved hypoxic cell radiosensitizers.

Wardman P and 3 others. Br J Cancer Suppl, 1978. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. The rationale for the development of improved hypoxic cell radiosensitizers. Papers, record 277207. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/277207

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The rationale for the development of improved hypoxic cell radiosensitizers.
PubMed
Journal
Br J Cancer Suppl
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.2
iCite
Revised in PubMed
2018-11-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wardman PP
2Clarke EDE D
3Flockhart IRI R
4Wallace RGR G

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Radiation-Sensitizing AgentsMajor topic
Nitroimidazoles
Oxidation-Reduction
Solubility
Structure-Activity Relationship

References10

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1330116The use of nitroaromatic compounds as hypoxic cell radiosensitizers.Curr Top Radiat Res Q1977https://conductscience.org/library/papers/330116PubMed
2985519Mammalian cell toxicity of nitro compounds : dependence upon reduction potential.Biochem Biophys Res Commun1976https://conductscience.org/library/papers/985519PubMed
34550859Linear relationships between lipophilic character and biological activity of drugs.J Pharm Sci1972https://conductscience.org/library/papers/4550859PubMed
44566530Lipophilic character and biological activity of drugs. II. The parabolic case.J Pharm Sci1973https://conductscience.org/library/papers/4566530PubMed
54213854Letter: Correlation of the efficiencies of some radiation sensitizers and their redox potentials.Int J Radiat Biol Relat Stud Phys Chem Med1974https://conductscience.org/library/papers/4213854PubMed
64537457Radiosensitization of mammalian cells by p-nitroacetophenone. II. Effectiveness of analogues.Int J Radiat Biol Relat Stud Phys Chem Med1972https://conductscience.org/library/papers/4537457PubMed
74540849Radiosensitization of mammalian cells by p-nitroacetophenone. 3. Effectiveness of nitrobenzene analogues.Int J Radiat Biol Relat Stud Phys Chem Med1973https://conductscience.org/library/papers/4540849PubMed
84895045Electron-affinic sensitization. I. A structural basis for chemical radiosensitizers in bacteria.Int J Radiat Biol Relat Stud Phys Chem Med1969https://conductscience.org/library/papers/4895045PubMed
9940937Electron-affinic sensitization. VII. A correlation between structures, one-electron reduction potentials, and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers.Radiat Res1976https://conductscience.org/library/papers/940937PubMed
106048497Nitroimidazole derivatives. Relationship between structure and antitrichomonal activity.J Med Chem1967https://conductscience.org/library/papers/6048497PubMed

Download CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn Papers
7370166Pharmacokinetic and tumour-penetration properties of the hypoxic cell radiosensitizer desmethylmisonidazole (Ro 05-Ro-9963) in dogs.Br J Cancer1980https://conductscience.org/library/papers/7370166

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/277207

GET https://conductscience.org/api/papers/v1/277207/authors